dextran
Small moleculeexperimental
Dextran 70 is a type of fluid given by injection into a vein to expand blood volume. Specifically it is used for shock such as that caused by bleeding or burns when blood transfusions are not quickly available. However, it does not carry oxygen. — Wikipedia
Clinical trial activity
26 trials · 30 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
9
Phase 3
3
Phase 4
6
Earliest trial started Oct 1, 1999 (NCT00004987)
Timeline
Indications
Approved for
Studied for
- Acute Kidney Injury · Phase 2/Phase 3
- Amyotrophic Lateral Sclerosis · Phase 2
- Autistic Disorder · Phase 1
- Brain Injuries · Phase 2/Phase 3
- Brain Injuries, Traumatic · Phase 3
- Cataract · Phase 4
- Conjunctivitis, Allergic · Phase 4
- Corneal Diseases · Phase 1/Phase 2
- Diabetes Mellitus, Type 1 · Phase 2
- Endocardial Cushion Defects · Phase 2
- Heart Defects, Congenital · Phase 2
- Heart Septal Defects, Ventricular · Phase 2
- HIV Infections · Phase 1
- Keratoconus · Phase 1/Phase 2
- Lacrimal Apparatus Diseases · Phase 1
- Liver Cirrhosis · Phase 2/Phase 3
- Macular Edema · Phase 4
- Motor Neuron Disease · Phase 2
- Peritonitis · Phase 4
- Transposition of Great Vessels · Phase 2
- Uveitis, Anterior · Phase 4
Mechanism of action
- UnclearSupplementation
Unclear supplementation
Chemistry & pharmacology
Loading structure…
SMILES
O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O- Mol. weight
- 504.44 g/mol
- Lipinski Ro5
- 3 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSJY83SHX053 ↗
- WikipediaDextran 70 ↗
- ChEMBLCHEMBL2108026 ↗
- ChEMBLCHEMBL1697742 ↗
- NCATSZNJ8R24I7Z ↗
- ChEMBLCHEMBL2108952 ↗
- NCATSI8LHQ0D645 ↗
- ChEMBLCHEMBL2108451 ↗
Also known as
- aquasite
- dextran
- dextran
- dextran
- dextran 40
- dextran 40
- dextran 40
- dextran 70
- dextran 70
- dextran 70
- dextran 70
- dextran sulfate
- dextran sulfate sodium
- infukoll
- low molecular weight sulfated dextran
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04944901 | Phase 1 | Aug 3, 2021 | Scioto Biosciences, Inc., University of Cincinnati |
| NCT05266690 | N/A | Nov 29, 2019 | Nestle |
| NCT03867851 | Phase 2 | Apr 15, 2019 | TikoMed AB |
| NCT03705390 | Phase 2 | Mar 29, 2019 | Neuregenix, TikoMed AB, University of Birmingham |
| NCT03613571 | Phase 2 | Aug 15, 2018 | TikoMed AB |
| NCT03934073 | N/A | Feb 2, 2018 | Centre Hospitalier St Anne |
| NCT02863809 | Phase 1/Phase 2 (Phase 2) | Mar 15, 2017 | Department of Defense, Harvard University |
| NCT03070353 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2015 | Mahidol University |
| NCT02507362 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2014 | Isfahan University, University of Tehran |
| NCT01732757 | Phase 4 | Nov 1, 2012 | Allergan |
| NCT01470118 | Phase 4 | Oct 1, 2011 | Allergan |
| NCT01978015 | Phase 4 | Oct 1, 2011 | University of Campinas |
| NCT01282138 | Phase 4 | Dec 1, 2010 | Alcon |
| NCT00789308 | Phase 2 | Jul 1, 2008 | Karolinska Institute, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Uppsala University |
| NCT00790439 | Phase 2 | Jul 1, 2008 | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Uppsala University |
| NCT00698724 | Phase 4 | Jun 1, 2008 | Bp Consulting, Inc |
| NCT00570960 | Phase 4 | Jun 1, 2007 | American Association for the Study of Liver Diseases, University of Virginia |
| NCT00266838 | Phase 1 | Jul 1, 2006 | Katholieke Universiteit Leuven |
| NCT00878631 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2004 | Defence Research and Development Canada, University of Toronto |
| NCT01642524 | Phase 3 | Apr 1, 2004 | Defence Research and Development Canada, University of Toronto |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (30)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 5 | 5 | 3 | 1999 |
| TikoMed AB | For profit | 3 | 2 | 1 | 2018 |
| Allergan | For profit | 2 | 2 | 1 | 2011 |
| Defence Research and Development Canada | Government | 2 | 0 | 1 | 2004 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 2 | 0 | 1 | 2008 |
| University of Toronto | Academic/Hospital | 2 | 2 | 1 | 2004 |
| Uppsala University | Academic/Hospital | 2 | 0 | 1 | 2008 |
| Alcon | For profit | 1 | 1 | 1 | 2010 |
| American Association for the Study of Liver Diseases | Academic/Hospital | 1 | 0 | 1 | 2007 |
| BioPhausia | For profit | 1 | 0 | 1 | 2003 |
| Bp Consulting, Inc | For profit | 1 | 1 | 1 | 2008 |
| Centre Hospitalier St Anne | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Department of Defense | Government | 1 | 0 | 1 | 2017 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Isfahan University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Mahidol University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2003 |
| Nestle | For profit | 1 | 1 | 1 | 2019 |
30 organizations
Page 1 / 2